Tower Research Capital LLC (TRC) - ALTAMIRA THERAPEUTICS LTD ownership

ALTAMIRA THERAPEUTICS LTD's ticker is and the CUSIP is G0360L100. A total of 21 filers reported holding ALTAMIRA THERAPEUTICS LTD in Q4 2021. The put-call ratio across all filers is 0.70 and the average weighting 0.0%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of ALTAMIRA THERAPEUTICS LTD
ValueSharesWeighting
Q2 2022$11,00022,649
+22549.0%
0.00%
Q1 2022$0
-100.0%
100
-98.5%
0.00%
Q4 2021$12,000
+500.0%
6,759
+656.9%
0.00%
Q3 2021$2,0008930.00%
Other shareholders
ALTAMIRA THERAPEUTICS LTD shareholders Q4 2021
NameSharesValueWeighting ↓
Ikarian Capital, LLC 320,010$351,0000.05%
BOOTHBAY FUND MANAGEMENT, LLC 30,753$34,0000.00%
Cutler Group LLC / CA 2,100$2,0000.00%
BARCLAYS PLC 1$00.00%
Gradient Investments LLC 1,000$1,0000.00%
Stonebridge Capital Advisors LLC 100$00.00%
UBS Group AG 3,486$4,0000.00%
OSAIC HOLDINGS, INC. 10$00.00%
WELLS FARGO & COMPANY/MN 500$1,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of ALTAMIRA THERAPEUTICS LTD shareholders